Payer and Policy Maker Steps to Support Value-Based Pricing for Drugs

JAMA. 2015 Dec 15;314(23):2503-4. doi: 10.1001/jama.2015.16843.

Authors

Peter B Bach¹, Steven D Pearson²

Affiliations

¹ Health Outcomes Research Group, Memorial Sloan Kettering Cancer Center, New York, New York.
² Institute for Clinical and Economic Review, Boston, Massachusetts.

PMID: 26619354
DOI: 10.1001/jama.2015.16843

No abstract available

MeSH terms

Administrative Personnel*
Costs and Cost Analysis
Drug Costs*
Health Expenditures
Humans
Insurance, Health, Reimbursement*
Prescription Drugs / economics*
United States
Value-Based Purchasing / organization & administration*

Substances

Prescription Drugs